Skip to main content
Signal8

Inventiva S.A. (IVA)

Inventiva S.A. is a biopharmaceutical company currently in its clinical development phase, specializing in the creation of orally administered small molecule therapeutics. The firm primarily targets serious conditions such as non-alcoholic steatohepatitis (NASH), various forms of mucopolysaccharidoses (MPS), and other significant diseases. The company's most advanced experimental drug is Lanifibranor, which has successfully completed Phase IIb clinical trials for the treatment of NASH. Inventiva is also progressing with Odiparcil, an asset that has finished its Phase IIa clinical studies for addressing the MPS VI subtype disease. Beyond these lead candidates, Inventiva maintains a robust pipeline of earlier-stage research and development programs, notably in oncology and other therapeutic areas. The company has also established important strategic alliances, including a partnership with AbbVie focused on treatments for autoimmune diseases, and a collaboration with Boehringer Ingelheim International GmbH aimed at discovering novel therapies for idiopathic pulmonary fibrosis. Inventiva S.A. was established in 2011 and is headquartered in Daix, France.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Inventiva S.A. logo

Inventiva S.A.

NASDAQ:IVAHealthcare
+3.06%$3.71
AH Close$3.66-1.35%vs close
Mkt Cap$876.43M
Float207.98M
O/S236.23M
Inst Own35.8%
SI4.0%
Dilution
Inventiva S.A. logoNASDAQ:IVA$3.71+3.06%
Delisting Issues Timeline
Financials Summary
Revenue$5.02M
Net Income-$380.74M
Total Assets$278.57M
Free Cash Flow-$113.3M
Debt & Equity
Debt 196%
Total Debt$66.48M
Total Equity-$32.5M
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in IVA's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$278.57M
Liabilities$311.07M
Accounts Receivable$10.2M
Accounts Payable$29.11M
Inventory$0
PP&E (Net)$3.33M
Goodwill$0
Intangible Assets$204K
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Revenue$5.02M$10.3M$19.56M$13.63M$4.69M$416K$7.83M$3.58M$7.3M$10.57M$5.46M$3.67M$3.43M
YoY Growth-51.3%-47.4%43.5%190.4%1027.4%-94.7%118.9%-51.0%-31.0%93.8%48.5%7.1%-
Cost of Revenue$3.13M$4.34M-$26K$1.11M$1.14M$947K$0$1.08M$1.38M$1.66M$1.57M$1.71M$1.88M
Gross Profit$1.69M$10.3M$19.59M$19.09M$4.69M$4.94M$7.83M$2.5M$5.92M$8.91M$3.88M$1.97M$1.55M
Gross Margin33.7%100.0%100.1%140.1%100.0%1187.4%100.0%69.8%81.0%84.3%71.2%53.6%45.1%
Research and Development$93.58M$101.72M$123.14M$67.68M$54.23M$26.55M$37.82M$35.41M$29.92M$24.79M$21.98M$18.23M$15.39M
Selling, General, and Administrative$60.32M$19.14M$17.47M$17.34M$12.89M$10.14M$5.05M$5.06M$4.62M$3.69M$3.61M$3.25M$3.4M
Other-$150K-$1.37M-$6.08M-$2.01M-$4.1M$1.52M-$2.34M$288K$0$0$0$0$0
Total Operating Expenses$153.75M$119.49M$134.52M$83.02M$63.03M$38.21M$40.53M$40.76M$30.21M$24.06M$22.11M$18.75M$17.38M
Operating Income (EBIT)-$146.57M-$109.2M-$114.96M-$63.92M-$58.33M-$33.26M-$33.93M-$37.22M-$23.41M-$14.57M-$17.36M-$15.07M-$13.95M
Operating Margin-2921.0%-1060.6%-587.7%-468.9%-1242.6%-7988.7%-433.2%-1040.1%-320.8%-137.8%-318.2%-410.2%-406.8%
Interest Expense$36.15M$13.63M$5.8M$791K$154K$74K$3K$272K$6K$8K$7K$3K$705
Interest Income$3.17M$1.28M$1.06M$437K$64K$253K$176K$158K$310K$258K$255K$307K$48K
Other Income (Expense)-$236.6M-$96.64M-$7.96M$3.15M$3.18M-$4.37M$106K-$124K$311K$515K$544K$834K$838K
Income Before Tax (EBT)-$383.17M-$205.84M-$122.92M-$60.77M-$55.15M-$37.63M-$33.82M-$37.34M-$23.1M-$14.06M-$16.82M-$14.24M-$13.12M
Income Tax Expense$25K$350K$679K-$22K$407K$0$0$283K-$3.82M-$6.17M-$6.94M-$5.85M-$5.13M
Net Income-$380.74M-$206.19M-$123.6M-$60.75M-$55.56M-$37.63M-$33.83M-$37.63M-$19.28M-$7.89M-$9.88M-$8.39M-$7.99M
Net Income Margin-7587.8%-2002.7%-631.8%-445.6%-1183.5%-9037.4%-431.9%-1051.5%-264.2%-74.6%-181.0%-228.3%-232.8%
Supplementary Data
EPS-1.82-3.54-2.43-1.31-1.27-0.99-1.28-1.64-1.11-0.45-0.88-0.75-0.71
Diluted EPS-1.82-3.54-2.43-1.31-1.27-0.99-1.28-1.64-1.11-0.45-0.88-0.75-0.71
Weighted Average OS186.80M51.98M45.35M41.45M39.17M33.87M23.52M20.54M15.52M15.68M10.03M10.03M10.03M
EBITDA-$142.96M-$186.39M-$114.21M-$62.08M-$58.98M-$34.4M-$32.05M-$35.87M-$24.03M-$11.65M-$15.57M-$13.91M-$12.78M
EBITDA Margin-2849.1%-1810.4%-583.9%-455.4%-1256.5%-8262.4%-409.2%-1002.4%-329.3%-110.2%-285.3%-378.5%-372.5%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Assets
Current Assets
Cash and Cash Equivalents$111.11M$108.08M$30.13M$97.08M$96.88M$118.3M$40.12M$63.46M$66.1M$27.83M$25.29M$19.18M$15.14M
Short-Term Investments$0$0$78K$1.17M$0$8.21M$0$0$0$0$0$0$0
Cash and Short-Term Investments$111.11M$108.08M$30.6M$98.26M$96.88M$126.51M$40.12M$63.46M$66.1M$27.83M$25.29M$19.18M$15.14M
Accounts Receivable$10.2M$13.61M$17.58M$312K$12.97M$54K$720K$14.9M$7.68M$5.04M$1.1M$3.59M$1.7M
Inventory$0$0$467K$417K$439K$358K$433K$459K$530K$528K$538K$534K$591K
Other Current Assets$147.19M$391K$77K$10.46M$10.74M$18.24M$12.88M$36K$0$15.17M$4.23M$0$0
Total Current Assets$272.93M$124.81M$53.94M$119.07M$129.37M$148.86M$54.71M$80.18M$75.24M$46.17M$32.03M$24.07M$18.13M
Long-Term Assets
Property, Plant & Equipment Net$3.33M$5.6M$10.22M$8.27M$3.58M$3.67M$4.16M$4.77M$5.05M$5.55M$6.24M$6.62M$6.75M
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$204K$54K$606K$636K$862K$1.05M$1.37M$1.73M$2.02M$2.32M$2.66M$2.47M$2.24M
Long-Term Investments$590K$1.27M$1.6M$784K$1.95M$1.9M$2.61M$2.54M$267K$432K$26.28M$0$0
Deferred Tax Assets$214K$243K$252K$0$782K$0-$2.61M-$2.54M$283K$218K$176K$126K$88K
Other Long-Term Assets$1.3M$1.17M$11.25M$1.08M-$2K$9K$3.51M$2.66M$373K$0$426K$48.58M$70.3M
Total Long-Term Assets$5.64M$8.35M$23.92M$10.77M$7.17M$6.63M$9.05M$9.15M$8M$8.52M$35.77M$57.79M$79.38M
Other Assets$0$0$0-$1K-$3K$0$3K$1K$0$2$3$0$0
Total Assets$278.57M$133.16M$77.86M$129.84M$136.54M$155.49M$63.76M$89.33M$83.24M$54.69M$67.8M$81.86M$97.51M
Liabilities
Current Liabilities
Accounts Payable$29.11M$36.78M$42.17M$21.67M$16.34M$7.75M$8.38M$9.37M$6.02M$4.89M$4.04M$2.11M$1.87M
Short-Term Debt$33.88M$3.75M$3.37M$5.12M$1.39M$18K$86K$2.38M$344K$163K$217K$66K$68K
Current Income Tax Payable$0$4.39M$3.99M$2.4M$1.18M$961K$946K$835K$672K$400K$199K$167K$278K
Current Unearned Revenue$0$0$7K$7K$0$0$2.36M$613K$663K$1.88M$1.92M$1.68M$1.68M
Other Current Liabilities$9.28M$82.16M$6.3M$2.55M$6.42M$6.23M$532K$2.11M$1.09M$1.22M$1.28M$1.26M$1.54M
Total Current Liabilities$86.57M$135.13M$56.14M$34.36M$25.58M$15.57M$15.52M$16.88M$9.84M$9.63M$8.67M$6.2M$6.29M
Long-Term Liabilities
Long-Term Debt$27.72M$51.85M$31.24M$28.46M$9.79M$11.24M$0$83K$246K$539K$564K$51K$111K
Long-Term Unearned Revenue$141K$120K$0$62K$0$0$0$1.87M$2.12M$1.17M$527K$377K$257K
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$10.41M-$2.12M$3.37M$10.17M$17.58M$24.8M
Other Long-Term Liabilities$193.53M$63.03M$21.55M$12.43M$1.6M$4.21M$1.9M$1.55M$1.5M$1.06M$0$377K$257K
Total Long-Term Liabilities$224.5M$117.39M$57.57M$44.58M$11.49M$15.45M$1.91M$3.51M$1.75M$5.08M$11.26M$18.01M$25.17M
Other Liabilities$0$0$1K$0$0$0$0$0$0$0$0$0$0
Total Liabilities$311.07M$252.53M$113.71M$78.94M$37.07M$31.01M$17.43M$20.39M$11.59M$14.7M$19.93M$24.21M$31.46M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0$0$0
Common Stock$2.16M$1.07M$583K$471K$458K$432K$300K$250K$184K$112K$112K$112K$112K
Retained Earnings-$396.39M-$206.19M-$123.6M-$60.75M-$55.56M-$37.63M-$33.82M-$37.63M-$19.28M-$7.89M-$9.88M-$8.39M-$7.99M
Comprehensive Income & Other-$228.95M-$193.14M-$138.78M-$83.45M-$30.2M$5.35M-$16.42M$19.62M$40.39M$47.76M$57.64M$65.93M$73.92M
Other Stockholders' Equity$361.73M$85.75M$87.16M$111.18M$154.57M$161.68M$79.85M$106.32M$90.75M$47.76M$57.64M$65.93M$73.92M
Total Equity-$32.5M-$119.37M-$35.85M$50.9M$99.47M$124.48M$46.33M$68.94M$71.65M$39.98M$47.87M$57.65M$66.05M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$278.57M$133.16M$77.86M$129.84M$136.54M$155.49M$63.76M$89.33M$83.24M$54.69M$67.8M$81.86M$97.51M
Supplementary Data
Total Debt$66.48M$60.81M$41.96M$38.63M$11.33M$11.26M$128K$2.47M$540K$702K$781K$117K$180K
Net Debt-$44.63M-$47.27M$11.83M-$58.45M-$85.55M-$103.46M-$39.99M-$60.99M-$65.56M-$27.13M-$24.51M-$19.07M-$14.96M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Operating Activities
Net Income-$380.74M-$206.19M-$123.6M-$60.75M-$55.56M-$37.63M-$33.82M-$37.63M-$19.28M-$7.89M-$9.88M-$8.39M-$7.99M
Depreciation & Amortization$3.61M$5.82M$2.91M$1.9M$1.03M$2.11M$1.77M$1.08M$1.59M$1.84M$1.46M$1.37M$1.55M
Deferred Income Tax-$2.57M-$5.37M-$5.31M-$5.89M-$3.66M-$8.57M-$4.81M-$5.28M-$8.81M-$10.98M-$10.98M-$9.17M-$7.57M
Stock-Based Compensation$29.96M$4.01M$4.44M$2.48M$2.34M$1.05M$1.57M$932K$765K$3.47M$76K$50K$2K
Changes in Working Capital:
  Accounts Receivable$914K$3.14M-$6.54M$4.3M-$5.95M-$514K$1.99M-$3.46M$2.04M-$3.21M-$189K-$41K$1.05M
  Inventory$0$467K-$49K$21K-$81K$76K$25K$34K-$1K$10K-$4K$57K-$591K
  Accounts Payable$2.75M$0$22.39M$3.96M$8.51M$1.42M-$3.33M$5.39M$3.73M$1.03M$2.16M$41K-$1.05M
  Other Working Capital$3.52M-$1.73M$3.57M-$1.89M-$1.38M-$3.19M$451K-$879K-$2.92M-$839K$2K$69K-$246K
Total Working Capital Change$7.18M$1.88M$19.37M$6.39M$1.1M-$2.21M-$861K$1.09M$2.85M-$3M$1.97M$86K$209K
Other Non-Cash Items$229.53M$103.68M$10.83M$5.57M$1.44M$11M$4.36M$1.52M$3.86M-$90K$1.71M-$503K-$4.13M
Net Cash from Operating-$113.03M-$96.18M-$91.35M-$50.29M-$53.31M-$34.24M-$31.79M-$38.29M-$19.03M-$16.63M-$15.65M-$16.55M-$17.92M
Investing Activities
Capital Expenditures-$266K-$373K-$604K-$628K-$598K-$327K-$152K-$614K-$479K-$255K-$1.08M-$1.45M-$2.15M
Acquisitions$0$0$0$46K$100K$0$3K$0$6.92M$19.51M$22.64M$22.27M$22.41M
Purchases of Investments-$142.93M$0-$9.29M-$1K-$1.51M-$9.25M-$776K$0$166K-$2K-$431K$0$0
Sales of Investments$0$10.16M$1.09M$10.51M-$100K$0$772K$144K$297K$19K$4K$0$0
Other Investing Activities-$1K$85K$147K$1K$101K$0-$772K$26K$706-$11K-$33K-$158K$296K
Net Cash from Investing-$143.19M$9.79M-$8.65M$9.93M-$2.01M-$9.58M-$925K-$470K$6.91M$19.26M$21.1M$20.67M$20.56M
Financing Activities
Debt Repaid$6.69M-$22.3M$4.59M-$31.83M$31K-$11.07M$309K$290K$163K$79K-$662K$66K-$185K
Common Stock Issuance$266.11M$64.18M$31.43M$9.88M$28.51M$113.92M$9.69M$36.41M$50.55M$0$0$0$84K
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$265K$76.48M$5.71M-$865K-$20K$0-$146K$1K$1K$0$0-$2K$84K
Net Cash from Financing$259.68M$162.96M$32.55M$41.71M$28.48M$125M$9.38M$36.12M$50.38M-$79K$662K-$68K$269K
Forex Effect$12.4M$1.38M$498K-$1.15M$5.42M-$3M$0$1K$0$0$0$0$0
Net Change in Cash$15.86M$77.95M-$66.95M$205K-$21.42M$78.18M-$23.34M-$2.64M$38.26M$2.54M$6.11M$4.05M$2.91M
Supplementary Data
Operating Cash Flow-$113.03M-$96.18M-$91.35M-$50.29M-$53.31M-$34.24M-$31.79M-$38.29M-$19.03M-$16.63M-$15.65M-$16.55M-$17.92M
Capital Expenditure-$266K-$373K-$604K-$628K-$598K-$327K-$152K-$614K-$479K-$255K-$1.08M-$1.45M-$2.15M
Free Cash Flow-$113.3M-$96.55M-$91.95M-$50.92M-$53.91M-$34.57M-$31.94M-$38.9M-$19.51M-$16.89M-$16.74M-$18M-$20.07M
Cash at Beginning$95.26M$30.13M$97.08M$96.88M$118.3M$40.12M$63.46M$66.1M$27.83M$25.29M$19.18M$15.14M$12.23M
Cash at End$111.11M$108.08M$30.13M$97.08M$96.88M$118.3M$40.12M$63.46M$66.1M$27.83M$25.29M$19.18M$15.14M